Reports
Global Hormonal Contraceptive Market Size, Statistics, Report: By Method: Pills, Intrauterine Devices (IUD), Injectables, Vaginal Ring, Implant, Patch; By Hormonals: Androgens, Estrogens, Progesterone, Antiandrogens, Gonadotrophins, Others; By Gender: Male, Female; By End User; Regional Analysis; Supplier Landscape; 2023-2031
Global Hormonal Contraceptive Market Outlook
The global hormonal contraceptive market size was valued at USD 16.8 billion in 2022, driven by the high rates of efficacy and reliability of hormonal contraceptives and the innovations in the market. The market is estimated to grow at a CAGR of 4.1% during the forecast period 2023-2031 to attain a value of USD 24.1 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Provide Significant Growth Opportunities to the Hormonal Contraceptive Industry
Geographically, North America is a significant region contributing to the growth of the hormonal contraceptive industry globally. The market growth in the region can be attributed to the increased awareness among people regarding hormonal contraceptives and their benefits. Hormonal contraceptives help prevent unwanted pregnancy. These are reliable and also provide relief from period pain and lead to lighter periods. They can be taken as pills, or can be injected, or inserted under the skin. Hormonal birth control also has some long-term advantages like it reduces the risk of uterus cancer and also reduces the risk of ovary cysts. These factors are driving the demand for hormonal contraceptives in the region. In addition, the availability of advanced healthcare infrastructure and clinical facilities are also enhancing the regional market growth.
Hormonal Contraceptive: Market Segmentation
Hormonal contraceptive refers to a type of birth control method that targets the endocrine system to prevent pregnancy. Hormonal contraceptives help prevent pregnancy by blocking the release of eggs from the ovaries. They contain estrogen and progesterone, or progesterone only, and may be taken by mouth, injected, or inserted under the skin. They influence hormone levels in women and prevent mature eggs from being released. However, they can have side effects such as headaches, nausea, mood swings, and other issues.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on method, the market can be segmented into:
- Pills
- Intrauterine Devices (IUD)
- Injectable
- Vaginal Ring
- Implant
- Patch
The EMR report looks into the regional markets of hormonal contraceptive like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Various Benefits of Hormonal Contraceptives and the Improving Healthcare Facilities to Bolster the Global Market for Hormonal Contraceptive
The high rates of efficacy and reliability of hormonal contraceptives and the innovations in the market are the key drivers for the hormonal contraceptive industry growth globally. Hormonal contraceptives can also relieve the symptoms of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Furthermore, hormonal birth control methods allow women to skip their periods by taking pills, contraceptive coils, or others, and, thus, help avoid menstrual migraines. They also reduce the risk of anaemia, as some women experience high bleeding during their periods, which may lead to fatigue and weakness. These factors are driving the growth of the industry. In addition, the growing research and development activities in the pharmaceutical sector and the improving healthcare infrastructure particularly in emerging economies are expected to further propel the market forward.
Key Industry Players in the Global Hormonal Contraceptive Market
The report presents a detailed analysis of the following key players in the global hormonal contraceptive market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions.
- Allergan Inc.
- Pfizer Inc.
- Bayer AG
- Afaxys, Inc.
- Merck and Co., Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Method |
|
| Breakup by Hormonals |
|
| Breakup by Gender |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hormonal Contraceptive Market Overview
3.1 Global Hormonal Contraceptive Market Historical Value (2016-2022)
3.2 Global Hormonal Contraceptive Market Forecast Value (2023-2031)
4 Global Hormonal Contraceptive Market Landscape
4.1 Global Hormonal Contraceptive Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hormonal Contraceptive Product Landscape
4.2.1 Analysis by Method
4.2.2 Analysis by Hormonals
4.2.3 Analysis by Gender
4.2.4 Analysis by End User
5 Global Hormonal Contraceptive Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hormonal Contraceptive Market Segmentation
6.1 Global Hormonal Contraceptive Market by Method
6.1.1 Market Overview
6.1.2 Pills
6.1.3 Intrauterine Devices (IUD)
6.1.4 Injectables
6.1.5 Vaginal Ring
6.1.6 Implant
6.1.7 Patch
6.2 Global Hormonal Contraceptive Market by Hormonals
6.2.1 Market Overview
6.2.2 Androgens
6.2.3 Estrogens
6.2.4 Progesterone
6.2.5 Antiandrogens
6.2.6 Gonadotrophins
6.2.7 Others
6.3 Global Hormonal Contraceptive Market by Gender
6.3.1 Market Overview
6.3.2 Male
6.3.3 Female
6.4 Global Hormonal Contraceptive Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Homecare
6.4.4 Clinics
6.4.5 Gynecology Centers
6.4.6 Ambulatory Surgical Centers (ASC)
6.5 Global Hormonal Contraceptive Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Hormonal Contraceptive Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hormonal Contraceptive Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hormonal Contraceptive Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hormonal Contraceptive Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hormonal Contraceptive Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Allergan Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Pfizer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bayer AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Afaxys, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck and Co., Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceutical Industries Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Sun Pharmaceutical Industries Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Reckitt Benckiser Group plc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Boehringer Ingelheim International GmbH.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Agile Technologies
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Warner Chilcott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Novartis AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Hormonal Contraceptive Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
It is estimated that the global market for hormonal contraceptive will reach USD 16.8 billion by 2022.
The market is anticipated to grow at a CAGR of 4.1% during the forecast period of 2023-2031 to reach a value of USD 24.1 billion by 2031.
The major drivers of the industry, such as the rising consumer awareness regarding contraceptives, increased investment by the key players to develop improved solutions and formulations, favourable government policies to control population explosion, and growing demand for oral pills, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing shift towards family planning, increasing R&D activities, and rapid technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Pills, intrauterine devices (IUD), injectable, vaginal ring, implant, and patch, among others, are the major methods of hormonal contraceptive in the industry.
The major players in the industry are Allergan Inc., Pfizer Inc., Bayer AG, Afaxys, Inc., and Merck and Co., Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER